D
MiNK Therapeutics, Inc. INKT
$14.57 -$0.33-2.22% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 34.03% 52.69% 51.98% 44.36% 34.23%
Total Depreciation and Amortization 4.90% -0.19% 5.23% 13.81% 25.69%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -43.29% -77.31% -84.58% -69.84% 3.01%
Change in Net Operating Assets -2.68% -86.41% -84.13% -58.99% -59.60%
Cash from Operations 36.80% 40.06% 39.38% 36.68% 34.93%
Capital Expenditure -- -- -- 100.00% 90.34%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- 100.00% 90.34%
Total Debt Issued -100.00% -100.00% -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -99.86% 18,124.76% 8,155.32% 8,143.63% 8,440.68%
Repurchase of Common Stock -- 100.00% 100.00% 100.00% 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -99.93% 17.82% 2,757.82% 2,758.48% 2,741.32%
Foreign Exchange rate Adjustments 70.76% -288.79% -116.67% -554.24% -65.03%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -483.28% 71.55% 107.44% 99.60% 93.19%